8
Participants
Start Date
November 30, 2022
Primary Completion Date
January 31, 2027
Study Completion Date
November 30, 2027
STEM-PD
STEM-PD is a cryopreserved cell product, consisting of ventral midbrain dopaminergic progenitor cells derived from the clinical-grade hESC line RC17. STEM-PD will be administered using a non-CE marked class III neurosurgical medical device, the Rehncrona-Legradi device, bilaterally in one surgical session to the putamen.
Region Skåne - Skåne University Hospital, Lund
Cambridge University Hospitals NHS Foundation Trust, Cambridge
Lund University
OTHER
Cambridge University Hospitals NHS Foundation Trust
OTHER
University of Cambridge
OTHER
Region Skane
OTHER